Published in Gynecol Oncol on April 01, 2003
The sentinel node in cervical cancer: scintigraphy and laparoscopic gamma probe-guided biopsy. Eur J Nucl Med Mol Imaging (2004) 1.56
A comprehensive overview of radioguided surgery using gamma detection probe technology. World J Surg Oncol (2009) 1.16
Sentinel node detection with (99m)Tc phytate alone is satisfactory for cervical cancer patients undergoing radical hysterectomy and pelvic lymphadenectomy. Int J Clin Oncol (2010) 1.00
Ultrastaging of lymph node in uterine cancers. J Exp Clin Cancer Res (2010) 0.98
Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2-IIB cervical cancer. Br J Cancer (2011) 0.97
Lymphatic mapping and sentinel node biopsy in gynecological cancers: a critical review of the literature. World J Surg Oncol (2008) 0.89
Detection of Sentinel Lymph Nodes in Gynecologic Tumours by Planar Scintigraphy and SPECT/CT. Mol Imaging Radionucl Ther (2012) 0.80
Sentinel lymph node biopsy in cervical cancer: A meta-analysis. Mol Clin Oncol (2013) 0.80
Sentinel-lymph-node procedures in early stage cervical cancer: a systematic review and meta-analysis. Med Oncol (2014) 0.77
Usefulness of sentinel lymph node detection in early stages of cervical cancer. Eur J Nucl Med Mol Imaging (2005) 0.77
Sentinel lymph nodes in gynaecological malignancies: frontline between TNM and clinical staging systems? Eur J Nucl Med Mol Imaging (2003) 0.76
Feasibility and performance of lymphoscintigraphy in sentinel lymph node biopsy for early cervical cancer: results of the prospective multicenter SENTICOL study. Ann Nucl Med (2014) 0.75
The sentinel node in gynaecological malignancies. Cancer Imaging (2006) 0.75
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol (2009) 2.45
Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol (2011) 2.35
Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma. Gynecol Oncol (2007) 2.18
The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease. Gynecol Oncol (2008) 2.14
Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer. Obstet Gynecol (2012) 2.09
Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer (2006) 2.03
Crystal structure of human iron regulatory protein 1 as cytosolic aconitase. Structure (2006) 2.01
Serendipitous discovery and X-ray structure of a human phosphate binding apolipoprotein. Structure (2006) 1.90
Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study. Ann Surg Oncol (2007) 1.84
Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity. Cancer Res (2003) 1.82
Human bocavirus infections in hospitalized children and adults. Emerg Infect Dis (2008) 1.77
Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: technique and review of the literature. Gynecol Oncol (2006) 1.73
Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging. Int J Gynecol Cancer (2013) 1.71
Subcutaneous tumor implantation after laparoscopic procedures in women with malignant disease. Obstet Gynecol (2004) 1.69
Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett (2009) 1.68
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol (2006) 1.64
The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered? Int J Gynecol Cancer (2011) 1.60
Radical abdominal trachelectomy for stage IB1 cervical cancer at 15-week gestation. Gynecol Oncol (2009) 1.57
Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches. Gynecol Oncol (2007) 1.56
Pelvic exenteration with curative intent for recurrent uterine malignancies. Gynecol Oncol (2011) 1.55
Automated analysis of vapor diffusion crystallization drops with an X-ray beam. Structure (2004) 1.53
The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. Gynecol Oncol (2012) 1.52
Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker. J Proteome Res (2007) 1.52
Raman-assisted crystallography reveals end-on peroxide intermediates in a nonheme iron enzyme. Science (2007) 1.52
The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol Oncol (2006) 1.51
French recommendations on the management of invasive cervical cancer during pregnancy. Int J Gynecol Cancer (2009) 1.48
Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer. Gynecol Oncol (2012) 1.47
Duodenum is important for the sphincter of Oddi motor response to cholecystokinin octapeptide in conscious dogs. J Gastroenterol (2005) 1.45
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecol Oncol (2010) 1.37
Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol Oncol (2009) 1.35
The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. Gynecol Oncol (2009) 1.33
Safety of Trans Vaginal Mesh procedure: retrospective study of 684 patients. J Obstet Gynaecol Res (2008) 1.31
Characterization and developmental gene regulation of a large gene family encoding amastin surface proteins in Leishmania spp. Mol Biochem Parasitol (2005) 1.30
Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. J Clin Oncol (2011) 1.29
The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. Gynecol Oncol (2007) 1.28
Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer. Gynecol Oncol (2008) 1.20
Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours. PLoS One (2008) 1.17
Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma. Gynecol Oncol (2008) 1.16
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma. Gynecol Oncol (2009) 1.14
Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer (2004) 1.12
Cystoscopic temporary ureteral catheterization during radical vaginal and abdominal trachelectomy. Gynecol Oncol (2006) 1.12
Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer. Gynecol Oncol (2011) 1.11
Radical vaginal versus abdominal trachelectomy for stage IB1 cervical cancer: a comparison of surgical and pathologic outcomes. Gynecol Oncol (2008) 1.10
Risks associated with laparoscopic entry: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur J Obstet Gynecol Reprod Biol (2011) 1.10
Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary. Gynecol Oncol (2006) 1.10
Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol (2003) 1.09
Nodal-staging surgery for locally advanced cervical cancer in the era of PET. Lancet Oncol (2012) 1.08
Radical trachelectomy for cervical cancer: postoperative physical and emotional adjustment concerns. Gynecol Oncol (2008) 1.08
Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasis. PLoS One (2011) 1.08
Tumor associated mesenchymal stem cells protects ovarian cancer cells from hyperthermia through CXCL12. Int J Cancer (2011) 1.07
Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: pilot data and comparison to laparotomy. Gynecol Oncol (2003) 1.07
The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. Gynecol Oncol (2007) 1.07
Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma. Gynecol Oncol (2007) 1.07
Reverse pH-dependence of chromophore protonation explains the large Stokes shift of the red fluorescent protein mKeima. J Am Chem Soc (2009) 1.06
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up. Int J Gynecol Cancer (2016) 1.06
Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons. J Infect Dis (2005) 1.06
The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers. Am J Obstet Gynecol (2005) 1.06
Structural basis of X-ray-induced transient photobleaching in a photoactivatable green fluorescent protein. J Am Chem Soc (2009) 1.05
Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed? Gynecol Oncol (2009) 1.05
Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC). Int J Gynecol Cancer (2013) 1.04
The role of reduced pterins in resistance to reactive oxygen and nitrogen intermediates in the protozoan parasite Leishmania. Free Radic Biol Med (2008) 1.04
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer. Gynecol Oncol (2011) 1.04
A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer. Gynecol Oncol (2010) 1.02
Cancer-related infertility in survivorship. Int J Gynecol Cancer (2010) 1.01
Biochemical and structural study of the homologues of the thiol-disulfide oxidoreductase DsbA in Neisseria meningitidis. J Mol Biol (2009) 1.01
X-ray radiation-induced damage in DNA monitored by online Raman. J Synchrotron Radiat (2006) 1.01
Clinical practice guidelines for the management of patients with endometrial cancer in France: recommendations of the Institut National du Cancer and the Société Française d'Oncologie Gynécologique. Int J Gynecol Cancer (2011) 1.00
Bilateral ultrastaging of sentinel lymph node in cervical cancer: Lowering the false-negative rate and improving the detection of micrometastasis. Gynecol Oncol (2012) 0.99
Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study. Int J Gynecol Cancer (2012) 0.99
The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum. Gynecol Oncol (2010) 0.99
Early behavioral adherence predicts short and long-term weight loss in the POUNDS LOST study. J Behav Med (2010) 0.98
Diffusion pathways of oxygen species in the phototoxic fluorescent protein KillerRed. Photochem Photobiol Sci (2010) 0.98
Sentinel lymph node biopsy in the management of early-stage cervical carcinoma. Gynecol Oncol (2011) 0.98
Ovarian cancer molecular pathology. Cancer Metastasis Rev (2012) 0.98
Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer. Gynecol Oncol (2005) 0.97
Pleural effusion detected at CT prior to primary cytoreduction for stage III or IV ovarian carcinoma: effect on survival. Radiology (2010) 0.97
Structural insights into a new homodimeric self-activated GTPase family. EMBO Rep (2007) 0.97
An international series on abdominal radical trachelectomy: 101 patients and 28 pregnancies. Int J Gynecol Cancer (2012) 0.97
Placental site trophoblastic tumor: analysis of presentation, treatment, and outcome. Gynecol Oncol (2012) 0.97
A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery. Gynecol Oncol (2012) 0.97
The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma. Gynecol Oncol (2011) 0.96
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer. Oncologist (2009) 0.96
Ten-year experience with laparoscopy on a gynecologic oncology service: analysis of risk factors for complications and conversion to laparotomy. Am J Obstet Gynecol (2004) 0.96
A new highly integrated sample environment for protein crystallography. Acta Crystallogr D Biol Crystallogr (2004) 0.95
Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer. Gynecol Oncol (2005) 0.95
A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery. Gynecol Oncol (2009) 0.95
Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Fertil Steril (2002) 0.95